An artificial pancreas has long been considered the holy grail for people with type 1 diabetes, and new research suggests a more convenient version of this technology may help the millions of people living with type 2 diabetes.
Every year, hibernating bears are able to feast, pack on a huge amount of weight and then lie around for months -- all without suffering the health consequence of diabetes. Now researchers are closer to understanding their secret.
Scientists with the Washington State University Bear Center say they've zeroed in on eight proteins that appear key to keeping hibernating grizzlies diabetes-pr...
Diane Kondyra knows a lot about the hidden dangers of diabetes.
Both she and her husband have been diagnosed with the blood sugar disease, and her husband suffered one of its devastating complications in 2018 when he developed a staph infection that cost him part of his leg. Uncontrolled diabetes can restrict blood flow to the legs, making it more likely that simple cuts can turn int...
Overall use of insulin pumps among U.S. youngsters with type 1 diabetes has climbed in recent decades, but those who are poor or from minority groups are less likely to have the devices, a new study finds.
Insulin pumps, which do away with the need for numerous painful injections, have been shown to ...
Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an "artificial pancreas" system may beat standard treatment in controlling the blood sugar disease in young children.
Forms of the technology -- which automatically monitors and regulates blood sugar -- are already available for adults and kids with
Scientists have known for 100 years that insulin is the body's main mechanism for controlling blood sugar levels, but researchers have now discovered a second hormone does the same job a bit differently -- and they say it could be a new target for treating diabetes.
The hormone, called FGF1, is produced in the body's fat tissue. Like
President Joe Biden promised cheaper prescription drugs for all Americans on Monday as his social agenda legislation winds its way through Congress.
Biden tried to shift Americans' focus to pocketbook provisions overlooked in his $2 trillion legislation, which deals with everything from climate to family life and taxes. The legislation has passed the House and is pending before the Senate...
Medtronic has expanded a recall of its MiniMed 600 series insulin pumps to include more than 463,000 of the devices.
The pumps may deliver incorrect dosing of insulin and the recall has been identified by the U.S. Food and Drug Administration as a Class I recall -- the most serious type -- because use of the recalled devices may cause serious harm or death.
Statins are proven to lower cholesterol, but they may also come with a downside for patients with diabetes: A new study finds they may make the blood sugar disease worse.
Researchers found that among those taking statins, 56% saw their diabetes progress, compared with 48% of those not taking statins. And the higher the dose of the statin, the faster the progression of the diabetes.
Potentially dangerous symptoms of type 1 diabetes in children are not always immediately recognized by primary care providers, new research suggests.
In type 1 diabetes, the pancreas fails to make enough insulin, the hormone that helps regulate blood sugar used for energy by cells. Between 5% and 10% of cases of diabetes are type 1, which often first surfaces in childhood.
U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday.
The agency's approval of an "interchangeable" biosimilar could save diabetics and health plans millions each year, the Associated Press reported. Until now, doctors have had to specifically prescribe ...
Black people have higher diabetes death rates than white people in the 30 largest cities in the United States, a new study finds.
But placing a cap on the price of insulin could narrow that racial gap, according to researcher Joanna Buscemi, of DePaul University in Chicago. Insulin medication is needed by all people with type 1 diabetes and many who have type 2, the more common form of th...
Daily insulin jabs can be the bane of existence for people who live with type 2 diabetes, but an investigational once-weekly insulin shot may be a game changer for these folks.
While the research is still in its early stages, the new drug called basal insulin Fc (BIF) is given once a week and appears to be just as effective at controlling blood sugar (glucose) as insulin degludec, the gol...
Researchers report that insulin can be stored at less-cold temperatures than previously known, potentially simplifying diabetes care for people in warmer regions that have fewer resources.
Researchers from Doctors Without Borders and the University of Geneva tested insulin storage in real conditions ranging from 77 to 98.6 degrees Fahrenheit for four weeks -- the time it typically takes t...
THURSDAY, Jan. 21, 2021 (HealthDay News) - - With rising obesity rates, more young women American women are developing type 2 diabetes, putting them at hugely increased risk for heart disease, new research shows.
In fact, the study found that women under 55 with type 2 diabetes had a tenfold greater risk of having heart disease over the next two decades compared to their non-diabetic peer...
Tough limits on carbohydrates in your meals can help get type 2 diabetes under control -- but the benefits typically wane over time, a new research review shows.
The analysis of 23 small trials found that low-carb diets worked better than other eating plans in helping people lose weight and send their type 2 diabetes into remission. That was true, at least, in the first six months.
Diabetics who've contracted COVID-19 should suspend their use of a class of common diabetes drugs known as sodium-glucose co-transporter 2 inhibitors (SGLT2i), new research warns.
People using these medications for diabetes are at risk of a potentially fatal complication called diabetic ketoacidosis (DKA), and it now appears that risk increases even more if they become sick with COVID-19,...
The earlier in life type 2 diabetes arises, the deadlier it is, a new analysis finds.
The study, which pooled the results of 26 previous ones, revealed a clear pattern: The younger people were when they developed type 2 diabetes, the greater their risk of complications like heart disease and stroke.
For each year type 2 diabetes was delayed, the risk of blood vessel diseases fell by...
A small study suggests that a new procedure that treats part of the intestine just beyond the stomach may allow people with type 2 diabetes to safely stop taking insulin.
The procedure -- which resurfaces the duodenum -- was combined with a popular kind of diabetes medication called GLP-1 receptor agonists (such as Victoza, Trulicity, Ozempic) and counseling on lifestyle factors, such a...
An experimental ultrafast-acting insulin could work four times quicker than current fast-acting formulas, researchers say.
For the study, the researchers focused on a form of insulin called monomeric insulin. Though its structure should, in theory, allow it to act faster, monomeric insulin is too unstable for practical use, so the Stanford University team had to find a way around that...
Rising prices have grabbed headlines as people struggle to afford their lifesaving insulin, but new research may have found an alternative for people with type 2 diabetes.
The study found that combining a wearable, patch-like insulin delivery device (called the V-Go) and an older, cheaper insulin could safely help people with type 2 diabetes achieve good blood sugar control.
Imagine needing insulin to live but a natural disaster suddenly cuts off access to your medication. New drone technology may one day come to the rescue by making urgent deliveries to remote locations, researchers say.
The world's first documented drone delivery of medications to a diabetes patient in a difficult-to-reach community is described in a new paper.
Obesity increases the risk for colon cancer, but weight-loss surgery may bring the risk back to normal, French researchers report.
People who are obese have a 34% higher risk of colon cancer than the general population, but any type of bariatric (weight-loss) surgery can bring their risk back in line, according to the authors of a new study.
If you don't need insulin, you probably haven't paid much attention to its skyrocketing cost, but new research shows that exorbitant drug pricing eventually affects everyone.
The study found that in 2017, Medicare spent nearly $8 billion on insulin. The researchers said that if Medicare were allowed to negotiate drug prices like the U.S. Department of Veterans Affairs (VA) can, Medic...